Literature DB >> 2172167

Bordetella pertussis adenylate cyclase toxin: intoxication of host cells by bacterial invasion.

M Mouallem1, Z Farfel, E Hanski.   

Abstract

Bordetella pertussis produces extracytoplasmic adenylate cyclase toxin (AC toxin) which penetrates target cells and, upon activation by host calmodulin, generates high levels of intracellular cyclic AMP (cAMP). As a result, bactericidal functions of immune effector cells are impaired. Since a considerable amount of AC toxin is associated with the bacterium, it was proposed that the toxin may be delivered by direct interaction of the organism with the target cells (E. L. Hewlett, M. C. Gray, and R. D. Pearson, Clin. Res. 35:477A, 1987). Incubation of CHO cells with intact B. pertussis led to formation of intracellular cAMP at levels comparable to those produced in CHO cells by equivalent activities of isolated AC toxin. cAMP accumulation induced by the whole bacteria appeared after a lag of 40 to 60 min and reached high levels within 2 to 3 h, whereas adherence of the bacteria proceeded rapidly and reached a maximal level within 80 min. Sera of pertussis patients completely blocked cAMP accumulation induced by the whole bacteria without having a major effect on either bacterial adherence or cAMP production by the AC toxin. Cytochalasins B and D, inhibitors of bacterial invasion, abrogated the cAMP response to the whole bacteria but not the response to the AC toxin. These agents did not affect bacterial adherence. Transmission electron micrographs revealed that B. pertussis, within the time course of cAMP induction, invaded CHO cells. We suggest that cAMP induction by B. pertussis is caused by the entry of the whole bacteria into CHO cells rather than by delivery of AC toxin during bacterial adherence. This route of cell intoxication may be relevant to the pathogenesis of whooping cough.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2172167      PMCID: PMC313725          DOI: 10.1128/iai.58.11.3759-3764.1990

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  27 in total

1.  A simple chemically defined medium for the production of phase I Bordetella pertussis.

Authors:  D W Stainer; M J Scholte
Journal:  J Gen Microbiol       Date:  1970-10

2.  A highly sensitive adenylate cyclase assay.

Authors:  Y Salomon; C Londos; M Rodbell
Journal:  Anal Biochem       Date:  1974-04       Impact factor: 3.365

3.  Bordetella pertussis invasive adenylate cyclase. Partial resolution and properties of its cellular penetration.

Authors:  E Hanski; Z Farfel
Journal:  J Biol Chem       Date:  1985-05-10       Impact factor: 5.157

4.  Calmodulin activates prokaryotic adenylate cyclase.

Authors:  J Wolff; G H Cook; A R Goldhammer; S A Berkowitz
Journal:  Proc Natl Acad Sci U S A       Date:  1980-07       Impact factor: 11.205

5.  Tn5-induced mutations affecting virulence factors of Bordetella pertussis.

Authors:  A A Weiss; E L Hewlett; G A Myers; S Falkow
Journal:  Infect Immun       Date:  1983-10       Impact factor: 3.441

6.  Pertussis toxin is required for pertussis vaccine encephalopathy.

Authors:  L Steinman; A Weiss; N Adelman; M Lim; R Zuniga; J Oehlert; E Hewlett; S Falkow
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

7.  Phagocyte impotence caused by an invasive bacterial adenylate cyclase.

Authors:  D L Confer; J W Eaton
Journal:  Science       Date:  1982-09-03       Impact factor: 47.728

8.  Characterization of antibody inhibiting adherence of Bordetella pertussis to human respiratory epithelial cells.

Authors:  E I Tuomanen; L A Zapiain; P Galvan; E L Hewlett
Journal:  J Clin Microbiol       Date:  1984-08       Impact factor: 5.948

9.  Extracytoplasmic adenylate cyclase of Bordetella pertussis.

Authors:  E L Hewlett; M A Urban; C R Manclark; J Wolff
Journal:  Proc Natl Acad Sci U S A       Date:  1976-06       Impact factor: 11.205

10.  Antibodies to Bordetella pertussis adenylate cyclase are produced in man during pertussis infection and after vaccination.

Authors:  Z Farfel; S Könen; E Wiertz; R Klapmuts; P A Addy; E Hanski
Journal:  J Med Microbiol       Date:  1990-07       Impact factor: 2.472

View more
  16 in total

1.  Role of adhesins and toxins in invasion of human tracheal epithelial cells by Bordetella pertussis.

Authors:  L Bassinet; P Gueirard; B Maitre; B Housset; P Gounon; N Guiso
Journal:  Infect Immun       Date:  2000-04       Impact factor: 3.441

2.  Neutralizing antibodies to adenylate cyclase toxin promote phagocytosis of Bordetella pertussis by human neutrophils.

Authors:  C L Weingart; P S Mobberley-Schuman; E L Hewlett; M C Gray; A A Weiss
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

3.  S-layer-mediated association of Aeromonas salmonicida with murine macrophages.

Authors:  R A Garduño; E J Lee; W W Kay
Journal:  Infect Immun       Date:  1992-10       Impact factor: 3.441

4.  Uptake and intracellular survival of Bordetella pertussis in human macrophages.

Authors:  R L Friedman; K Nordensson; L Wilson; E T Akporiaye; D E Yocum
Journal:  Infect Immun       Date:  1992-11       Impact factor: 3.441

5.  Bordetella pertussis induces respiratory burst activity in human polymorphonuclear leukocytes.

Authors:  L L Steed; E T Akporiaye; R L Friedman
Journal:  Infect Immun       Date:  1992-05       Impact factor: 3.441

6.  Bordetella adenylate cyclase toxin interacts with filamentous haemagglutinin to inhibit biofilm formation in vitro.

Authors:  Casandra Hoffman; Joshua Eby; Mary Gray; F Heath Damron; Jeffrey Melvin; Peggy Cotter; Erik Hewlett
Journal:  Mol Microbiol       Date:  2016-11-03       Impact factor: 3.501

7.  Bordetella pertussis induces apoptosis in macrophages: role of adenylate cyclase-hemolysin.

Authors:  N Khelef; A Zychlinsky; N Guiso
Journal:  Infect Immun       Date:  1993-10       Impact factor: 3.441

8.  Suppression of platelet aggregation by Bordetella pertussis adenylate cyclase toxin.

Authors:  M Iwaki; K Kamachi; N Heveker; T Konda
Journal:  Infect Immun       Date:  1999-06       Impact factor: 3.441

9.  Quantification of the adenylate cyclase toxin of Bordetella pertussis in vitro and during respiratory infection.

Authors:  Joshua C Eby; Mary C Gray; Jason M Warfel; Christopher D Paddock; Tara F Jones; Shandra R Day; James Bowden; Melinda D Poulter; Gina M Donato; Tod J Merkel; Erik L Hewlett
Journal:  Infect Immun       Date:  2013-02-19       Impact factor: 3.441

10.  Bordetella pertussis infection of primary human monocytes alters HLA-DR expression.

Authors:  Jennifer A Shumilla; Vashti Lacaille; Tara M C Hornell; Jennifer Huang; Supraja Narasimhan; David A Relman; Elizabeth D Mellins
Journal:  Infect Immun       Date:  2004-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.